Cherry angiomas are the most common vascular proliferation; however, little is known about the pathogenesis and etiology of these lesions. We present two laboratory technicians who were exposed to brominated compounds for prolonged periods and who developed multiple cherry angiomas on the trunk and extremities. We suggest that the association between exposure to bromides and cherry angiomas should be investigated by a controlled study.

Keywords:
Cherry angiomas, Bromides
1.
James LP, Farrar HC, Griebel ML, Bates SR: Bromism: Intoxication from a rare anticonvulsant therapy. Pediatr Emerg Care 1997;13:268–270.
2.
Baumeister FA, Eife R: Der Bromismus oder die chronische Bromidintoxikation. Klin Pädiatr 1993;205:432–434.
3.
Pelckmans MC, Verdickt W, Verberckmoes R, Van Boven M, Lissens W, Schurmans P, Daenens P: Bromism: Rare but still present. Acta Clin Belg 1983;38:397–400.
4.
David M, Ingber A, Sandbank M, Feuerman J: Bromoderma caused by carbromalhydroxyzine hydrochloride. Biomed Pharmacother 1983;37:298–300.
5.
Diener W, Sorni M, Ruile S, Rude P, Kruse R, Becker E, Bork K, Berg PA: Panniculitis due to potassium bromide. Brain Dev 1998;20:83–87.
6.
Pfeifle J, Grieben U, Bork K: Bromoderma tuberosum durch antikonvulsive Behandlung mit Kaliumbromid. Hautarzt 1992;43:792–794.
7.
Chu P, Le Boit PE: An eruptive vascular proliferation resembling acquired tufted angioma in the recipient of a liver transplant. J Am Acad Dermatol 1992;26:322–325.
8.
Garnis S, Billick RC, Srolovitz H: Eruptive vascular tumors associated with chronic graft-versus-host disease. J Am Acad Dermatol 1984;10:918–921.
9.
De Felipe I, Redondo P: Eruptive angiomas after treatment with cyclosporine in a patient with psoriasis (letter). Arch Dermatol 1998;134:1487–1488.
10.
Firooz A, Komeili A, Dowlati Y: Eruptive melanocytic nevi and cherry angiomas secondary to exposure to sulfur mustard gas (letter). J Am Acad Dermatol 1999;40:646–647.
11.
Raymond LW, Williford LS, Burke WA: Eruptive cherry angiomas and irritant symptoms after one acute exposure to the glycol ether solvent 2-butoxyethanol. J Occup Environ Med 1998;40:1059–1064.
12.
Wollina U, Zielinski M, Knopf B, Hipler C: Eruptives kapilläres Hämangiom nach Argonlaser-Therapie eines Naevus flammeus. Hautarzt 1989;40:212–214.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.